Medication info
Colensina Soft Gel Capsule (Choline Alphoscerate)

Colensina Soft Gel Capsule (Choline Alphoscerate)

Prescription medicationSoft capsuleOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 capsule
Manufacturer / importer
KUKJE pharmaceutical co., ltd
Appearance
Yellow-brown oval soft gel capsule filled with a colorless transparent liquid
Packaging
90 capsules/box [10 capsules/PTP X 9]
Approval status
Active

MFDS item code 202008371 · Approved 2020.11.30 · Insurance code 643705240

Summary

Main use
Improvement of cerebrovascular and degenerative organic brain symptoms (including memory impairment and confusion)
Who takes it
Adults
Adult dose
Administer 400 mg of choline alfoscerate orally per dose, 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Ingredients

Importer
KUKJE pharmaceutical co., ltd

Efficacy & effects

Improvement of cerebrovascular and degenerative organic brain symptoms (including memory impairment and confusion)

  • Memory decline
  • confusion
  • disorientation
  • decreased motivation
  • decreased spontaneity
  • reduced concentration
View approved original text

This medication is used for secondary symptoms due to cerebrovascular deficits and degeneration or degenerative organic brain syndromes. It helps improve symptoms such as memory decline, confusion, decreased motivation and spontaneity, disorientation, and reduced concentration. Clinical trial results in South Korea have confirmed these effects. Therefore, this drug is effective in improving various symptoms related to decreased brain function.

How to take

Adult dose

Administer 400 mg of choline alfoscerate orally per dose, 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Precautions

This medication should not be used by patients who are allergic to this medication or its components. Additionally, women who are pregnant or may become pregnant should not take this medication. Nausea may occur when taking this medication, which may be due to the action of the neurotransmitter dopamine in the brain. In such cases, the dosage should be reduced. It can affect the gastrointestinal system and may cause gastritis or other gastric disorders. It may also have an effect on the mental and neurological systems, resulting in drowsiness, insomnia, irritability, or nervousness; in severe cases, seizures or excessive motor behavior may occur. This medication must be stored out of reach of children in a safe place. Additionally, transferring to another container may cause accidents or reduce the quality of the medication, so it should be stored in its original container.

Side effects

  • Nausea
  • gastritis
  • stomach disease
  • drowsiness
  • insomnia
  • aggression
  • irritability
  • convulsions
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or humidity; therefore, it must be stored in a tightly sealed container. The storage temperature should be kept at room temperature between 1 degree and 30 degrees Celsius for safety.

Appearance and packaging

Appearance

Yellow-brown oval soft gel capsule filled with a colorless transparent liquid

Package unit

90 capsules/box [10 capsules/PTP X 9]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.